Literature DB >> 8375924

Hair dyes, analgesics, tranquilizers and perineal talc application as risk factors for ovarian cancer.

A Tzonou1, A Polychronopoulou, C C Hsieh, A Rebelakos, A Karakatsani, D Trichopoulos.   

Abstract

In a hospital-based case-control study of ovarian cancer conducted in Athens (1989-1991), 189 women with histologically confirmed common malignant epithelial tumors of the ovary were compared with 200 hospital visitor controls. All interviews were conducted by personal interview in the 2 participating hospitals and the data were analyzed by modelling through logistic regression, controlling for demographic and reproductive variables. Tranquilizing and hypnotic drugs (mostly diazepam) were not associated with risk of ovarian cancer: the adjusted relative risk (RR) and 95% confidence interval (CI) were 0.96 (0.57 to 1.63), whereas use of analgesics (mostly salicylates) was associated with significantly reduced risk of the disease (RR 0.51; CI 0.26 to 1.02). There was no evidence that perineal application of talc was associated with increased risk (RR 1.05; CI 0.28 to 3.98) but the frequency of reporting talc use was low in the study population. There was a statistically significant (p for trend 0.007) and a dose-dependent association between hair dyeing and risk of ovarian cancer. Compared to never-users, women dyeing their hair up to 4 times per year had a relative risk of 1.74 (0.91 to 3.32) whereas those dyeing their hair 5 or more times per year had a relative risk of 2.16 (1.19 to 3.89).

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8375924     DOI: 10.1002/ijc.2910550313

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  19 in total

1.  Use of nonsteroidal anti-inflammatory drugs and risk of ovarian and endometrial cancer: the Multiethnic Cohort.

Authors:  Veronica Wendy Setiawan; Rayna K Matsuno; Galina Lurie; Lynne R Wilkens; Michael E Carney; Brian E Henderson; Laurence N Kolonel; Marc T Goodman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-04       Impact factor: 4.254

2.  Do nonsteroidal anti-inflammatory drugs affect the risk of developing ovarian cancer? A meta-analysis.

Authors:  Stefanos Bonovas; Kalitsa Filioussi; Nikolaos M Sitaras
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

3.  Nonsteroidal anti-inflammatory drugs and risk for ovarian and endometrial cancers in the Iowa Women's Health Study.

Authors:  Anna E Prizment; Aaron R Folsom; Kristin E Anderson
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02       Impact factor: 4.254

Review 4.  Non-steroidal anti-inflammatory drug use and ovarian cancer risk: findings from the NIH-AARP Diet and Health Study and systematic review.

Authors:  Megan A Murphy; Britton Trabert; Hannah P Yang; Yikyung Park; Louise A Brinton; Patricia Hartge; Mark E Sherman; Albert Hollenbeck; Nicolas Wentzensen
Journal:  Cancer Causes Control       Date:  2012-09-13       Impact factor: 2.506

5.  Cellular and molecular damage of Phanerochaete chrysosporium by the oxidation hair dyes.

Authors:  Hongxia Xiong; Qixing Zhou
Journal:  Environ Sci Pollut Res Int       Date:  2012-01-10       Impact factor: 4.223

6.  Aspirin, nonaspirin nonsteroidal anti-inflammatory drugs, or acetaminophen and risk of ovarian cancer.

Authors:  Wei-Hsuan Lo-Ciganic; Janice C Zgibor; Clareann H Bunker; Kirsten B Moysich; Robert P Edwards; Roberta B Ness
Journal:  Epidemiology       Date:  2012-03       Impact factor: 4.822

Review 7.  Epidemiological and genetic factors associated with ovarian cancer.

Authors:  Monica R McLemore; Christine Miaskowski; Bradley E Aouizerat; Lee-May Chen; Marylin J Dodd
Journal:  Cancer Nurs       Date:  2009 Jul-Aug       Impact factor: 2.592

Review 8.  Perineal talc use and ovarian cancer: a critical review.

Authors:  Joshua E Muscat; Michael S Huncharek
Journal:  Eur J Cancer Prev       Date:  2008-04       Impact factor: 2.497

9.  Personal use of hair dye and cancer risk in a prospective cohort of Chinese women.

Authors:  Julie Bloch Mendelsohn; Qi-Zhai Li; Bu-Tian Ji; Xiao-Ou Shu; Gong Yang; Hong-Lan Li; Kyoung-Mu Lee; Kai Yu; Nathaniel Rothman; Yu-Tang Gao; Wei Zheng; Wong-Ho Chow
Journal:  Cancer Sci       Date:  2009-03-09       Impact factor: 6.716

10.  Genital powder use and risk of ovarian cancer: a pooled analysis of 8,525 cases and 9,859 controls.

Authors:  Kathryn L Terry; Stalo Karageorgi; Yurii B Shvetsov; Melissa A Merritt; Galina Lurie; Pamela J Thompson; Michael E Carney; Rachel Palmieri Weber; Lucy Akushevich; Wei-Hsuan Lo-Ciganic; Kara Cushing-Haugen; Weiva Sieh; Kirsten Moysich; Jennifer A Doherty; Christina M Nagle; Andrew Berchuck; Celeste L Pearce; Malcolm Pike; Roberta B Ness; Penelope M Webb; Mary Anne Rossing; Joellen Schildkraut; Harvey Risch; Marc T Goodman
Journal:  Cancer Prev Res (Phila)       Date:  2013-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.